Biodexa Pharmaceuticals (BDRX) Exchange Rate Effect (2014 - 2021)
Biodexa Pharmaceuticals (BDRX) reported Exchange Rate Effect of -$8088.1 for Q4 2021, down 103.21% on a YoY basis from $252206.1 in Q4 2020, and up 2.98% sequentially from -$8336.9 in Q3 2021.
Biodexa Pharmaceuticals (BDRX) Exchange Rate Effect (2014 - 2021) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 5 years of Exchange Rate Effect data on file, last reported at -$8088.1 in Q4 2021.
- For the quarter ending Q4 2021, Exchange Rate Effect fell 103.21% year-over-year to -$8088.1; the trailing twelve-month figure through Dec 2021 stood at $476303.7 (up 33.76% YoY), and the FY2022 full-year result was -$1237.6, up 88.76% from the prior year.
- Exchange Rate Effect rose to -$8088.1 in Q4 2021, from -$8336.9 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $252206.1 in Q4 2020 to a low of -$84857.8 in Q4 2019.
- A 4-year average of $56611.2 and a median of -$8212.5 in 2021 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect soared 397.21% in 2020 and tumbled 103.47% in 2021, its largest moves.
- Tracing BDRX's Exchange Rate Effect over 4 years: stood at -$51778.9 in 2017, then sank by 63.88% to -$84857.8 in 2019, then soared by 397.21% to $252206.1 in 2020, then tumbled by 103.21% to -$8088.1 in 2021.
- Business Quant data shows BDRX's Exchange Rate Effect at -$8088.1 in Q4 2021, -$8336.9 in Q3 2021, and $252206.1 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 17.77 Bn | 17.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -8,088.06 |
| Dec 31, 2021 | -8,088.06 |
| Sep 17, 2021 | -8,336.91 |
| Sep 17, 2021 | -8,336.91 |
| Dec 31, 2020 | 252,206.14 |
| Dec 31, 2020 | 252,206.14 |
| Sep 10, 2020 | 240,522.55 |
| Sep 10, 2020 | 240,522.55 |
| Dec 31, 2019 | -84,857.84 |
| Dec 31, 2019 | -84,857.84 |
| Dec 31, 2017 | -51,778.93 |
| Dec 31, 2017 | -51,778.93 |
| Dec 31, 2014 | -58,622.92 |
| Dec 31, 2014 | -58,622.92 |